CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market buy Director bought 220,000 shares at $0.44 ($96,800)
- 4/A Open-market buy Director bought 98,500 shares at $0.41 ($40,385)
- 4 Open-market buy Director bought 270,000 shares at $0.37 ($99,900)
- 4 Open-market buy Director bought 195,000 shares at an average $0.27 ($53,450)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.28 ($1,400)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 100,000 shares at $0.41 ($41,000)
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 4,000 shares at $1.48 ($5,920)
- 8-K Event Auditor change
- S-3 Offering Registration Statement
Page 28 of 45 · 895 filings